Product Name: MEM-101A (IgG1)
Background: CD29 (beta1 integrin subunit, GPIIa) forms non-covalently linked heterodimers with at least 6 different alpha chains (alpha1-alpha6, CD49a-f) determining the binding properties of beta1 (VLA) integrins. These integrins mediate cell adhesion to collagen, f
Specificity: The antibody MEM-101A reacts with CD29 (integrin beta1 chain), a 130 kDa single chain type I glycoprotein expressed as a heterodimer (non-covalently associated with the integrin alpha subunits 1-6). CD29 is broadly expressed on majority of hematopoietic a
Immunogen: Raji Burkitts lymphoma cell line
CAS NO: 275371-94-3
Product: Taspoglutide
Species Reactivity: HumanPorcineCanine (Dog)
Negative Species: Mouse
Applications: Flow CytometryRecommended dilution:2 μg/mlImmunoprecipitationWestern BlottingRecommended dilution:2 μg/mlPositive control:JURKAT human leukemia T-cell lysateKg-1a human leukemia cell lysateSample preparation:buffer with laurylmaltoside, 2 x non-
PubMed ID:http://aac.asm.org/content/49/7/2895.abstract
Product Name: MEM-101A (IgG1)
Background: CD29 (beta1 integrin subunit, GPIIa) forms non-covalently linked heterodimers with at least 6 different alpha chains (alpha1-alpha6, CD49a-f) determining the binding properties of beta1 (VLA) integrins. These integrins mediate cell adhesion to collagen, f
Specificity: The antibody MEM-101A reacts with CD29 (integrin beta1 chain), a 130 kDa single chain type I glycoprotein expressed as a heterodimer (non-covalently associated with the integrin alpha subunits 1-6). CD29 is broadly expressed on majority of hematopoietic a
Immunogen: Raji Burkitts lymphoma cell line
CAS NO: 1346527-98-7
Product: ML240
Species Reactivity: HumanPorcineCanine (Dog)
Negative Species: Mouse
Applications: Flow CytometryRecommended dilution:2 μg/mlImmunoprecipitationWestern BlottingRecommended dilution:2 μg/mlPositive control:JURKAT human leukemia T-cell lysateKg-1a human leukemia cell lysateSample preparation:buffer with laurylmaltoside, 2 x non-
PubMed ID:http://aac.asm.org/content/50/6/1993.abstract